Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
C.GRCM | 5 hours ago VANCOUVER, BC, June 7, 2024 – Geologica Resource Corp. (CSE:GRCM, FSE:862 ) (“Geologica” or the “Company”) is pleased to announce the closing of its previously announced financing and property acquisition. The Company intends to issue 4,301,450 Units at $0.035 per unit for total proceeds of $150,550 (the “Units”) each Unit consists of a share and a whole warrant. Each warrant may be exercised for 1 (one) share for 2 (two) years from closing for $0.05. A warrant holder must exercise the Warrant, within 30 days of the shares of the Company trading at a 20 day VWAP of $0.20 or greater once the 4 month statutory hold has expired. The Company paid finders fees of $10,928 and issued 312,229 finders warrants. The warrants have the same terms as above. The proceeds of the financing will be used for exploration work and general administration. In a sperate transaction the Company issued 2,000,000 shares to complete the acquisition of the Topley West Property as announced March 28, 2024. The Company has also issued 100,000 shares at a deemed price of $0.045 to settle outstanding debt with an unrelated party. The securities issued under the financing will be subject to restrictions on resale for 4 (Four) months and a day, pursuant to applicable Canadian securities laws and the rules of the Canadian Securities Exchange. TOPLEY LANDING PROJECT TOPLEY LANDING PROJECT The claims to be explored at Topley Landing are overlapped by Lake Babine Nation (LBN) traditional territory; In consultation with the Lake Babine Nation, Geologica has been granted access to Topley for completion of an IP survey; Geochemistry has identified high priority exploration target areas and kilometer-scale VMS target areas; The region is known for its large porphyry, copper/gold, and copper/molybdenum deposits including the on-trend past-producing Granisle and Bell copper mines; American Eagle Gold Corp. has discovered a copper deposit on trend with Topley; The property is located in central BC, is road accessible and cost effective to explore year round BC Hydro power lines transect the property and several water sources are available on the property; Rail Access to tide water is only 40km away; Porphyries contain the largest reserves of Copper and close to 50% of gold reserves in BC; Topley Property consists of 11 mineral claims totaling 4,216 Ha with six known prospects and showings. About Geologica Resource Corp. Geologica Resource Corp. is a mineral explorer, building shareholder value through the acquisition of projects with significant technical merit. The Company has an option agreement and a purchase agreement for 100% of the mineral claims known as the Topley Project, located in central British Columbia. Further information on Geologica Resource Corp. can be found on the Company’s website https://geologicaresource.com/ and on SEDAR at https://www.sedarplus.ca Doug Unwin President & CEO (604) 762-5355 doug.unwin@geologicaresource.com Forward-Looking Statements This news release contains forward-looking information which is not comprised of historical facts. Forward-looking information is characterized by words such as “plan”, “expect”, “ensuring”, “believe”, “anticipate”, “will”, “would” and other similar words, or statements that certain events or conditions “may” or “will” occur. In particular, this news release contains forward-looking information pertaining to the Company’s plans and objectives with respect to the Topley Project. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, changes in the state of equity and debt markets, fluctuations in commodity prices, delays in obtaining required regulatory or governmental approvals, environmental risks, limitations on insurance coverage, failure to obtain all necessary regulatory approvals, risks and uncertainties inherent in the exploration and development of mineral properties, and other risk factors set forth in the long-form prospectus of the Company dated July 22, 2022 under the heading “Risk Factors”, a copy of which is available on the Company’s SEDAR profile at www.sedarplus.ca. Forward-looking information in this news release is based on the opinions and assumptions of management considered reasonable as of the date hereof, including, but not limited to, the assumption that general business and economic conditions will not change in a materially adverse manner. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information. The Company disclaims any intention or obligation to update or revise any forward-looking information, other than as required by applicable securities laws. Tags: INDUSTRIAL METALS & MINERALS 0 Related News @ the Bell: Resource stocks lift TSX 21 hours ago @ the Bell: How did markets react to the BoC rate cut? 1 day ago @ the Bell: TSX hits one-month low 2 days ago Recent U.S. Press Releases Geologica Closes Financing And Property Acquisition 5 hours ago INDUSTRIAL METALS & MINERALS ADDITION OF NEW COPPER CLAIMS AT TOPLEY PROJECT April 18, 2024 INDUSTRIAL METALS & MINERALS Xcyte Digital Corp. Purchases Assets of A+ Conferencing April 3, 2024 TECHNOLOGY More Press Releases » Featured News Links Flow Test and Laboratory Analysis Confirm a Major New HELIUM Discovery in Minnesota This Small-Cap Gold Stock Keeps Notching Up High-Grade Gold in Nevada Thematic Insights: Free Podcast Exploring Market Trends & Emerging Sectors Get the latest news and updates from Stockhouse on social media facebook twitter linkedin Follow STOCKHOUSE Today (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Amicus Therapeutics Inc FOLD

Healthcare Biotechnology
Amicus Therapeutics, Inc. is a biotechnology company, which is focused on discovering, developing, and delivering novel medicines for rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease relevant tissues for adults living with late-onset Pompe disease. As an orally administered monotherapy, Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A (alpha-Gal A) enzyme in those patients with genetic variants identified as amenable in a Good Laboratory Practice (GLP) cell-based amenability assay. Pombiliti + Opfolda consists of a uniquely engineered rhGAA enzyme, cipaglucosidase alfa-atga, with an optimized carbohydrate structure to enhance lysosomal uptake, administered in combination with miglustat that functions as an enzyme stabilizer.


NDAQ:FOLD - Post by User

Amicus Therapeutics Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by mark26on Sep 06, 2014 9:35pm
140 Views
Post# 22913229

RE:RE:FOLD had two signals consecutive days!

RE:RE:FOLD had two signals consecutive days!
Fold can be a big winner if it get FDA ok in near future.

I can see big farma to buyout,,,,,

I can be wrong but you never know what can happen?

My 2 cents into this story.

Mark
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities